Are the definitions of functional digestive disorders based on the Rome criteria useful in clinical practice?;Définition des troubles fonctionnels digestifs par les critères de Rome: Quelle utilité pour le clinicien?

Gastroenterologie Clinique et Biologique

Volumn 28, Issue 6-7 I, 2004, Pages 551-553

  Delvaux, Michel ^a   Gay, Gérard ^a  

^a CHU NANCY BRABOIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL DISTENSION; ABDOMINAL PAIN; CLINICAL PRACTICE; CONSTIPATION; DIARRHEA; DISEASE CLASSIFICATION; EDITORIAL; HUMAN; INTESTINE FUNCTION DISORDER; IRRITABLE COLON; ITALY;

EID: 3142781953     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0399-8320(04)95010-5     Document Type: Editorial

References (38)

1. Thompson WG, Creed F, Drossman DA, Heaton K, Mazzacca G. Functional bowel disease and abdominal pain. Gastroenterol Int 1992; 5:75-91.
2. Kay L, Jorgensen T, Lanng C. Irritable bowel syndrome: which definitions are consistent? J Intern Med 1998;244:489-94.
3. Veldhuyzen van Zanten SJ, Talley NJ, Bytzer P, Klein KB, Whorwell PJ, Zinsmeister AR. Design of treatment trials for functional gastrointestinal disorders. Gut 1999;45(Suppl 2):1169-1177.
4. Delvaux M, Louvel D, Lagier E, Scherrer B, Abitbol JL, Frexinos J. The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome. Gastroenterology 1999;116: 38-45.
5. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999;45(Suppl 2):1143-1147.
6. Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ, III. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991;101:927-34.
7. Longstreth GF, Wolde-Tsadik G. Irritable bowel-type symptoms in HMO examinees. Prevalence, demographics, and clinical correlates. Dig Dis Sci 1993;38:1581-9.
8. Thompson WG, Irvine EJ, Pare P, Ferrazzi S, Rance L. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 2002;47:225-35.
9. Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J 1978;2:653-4.
10. Kruis W, Thieme C, Weinzierl M, Schussler P, Holl J, Paulus W. A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology 1984;87:1-7.
11. Boyce PM, Koloski NA, Talley NJ. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterol 2000;95:3176-83.
12. Chey WD, Olden K, Carter E, Boyle J, Drossman D, Chang L. Utility of the Rome I and Rome II criteria for irritable bowel syndrome in U.S. women. Am J Gastroenterol 2002;97:2803-11.
13. Mearin F, Roset M, Badia X, Balboa A, Baro E, Ponce J, et al. Splitting irritable bowel syndrome: from original Rome to Rome II criteria. Am J Gastroenterol 2004;99:122-30.
14. Bommelaer G, Poynard T, LePen C, Gaudin AF, Maurel F, Priol G, et al. Prévalence du syndrome de l'intestin irritable (SII) et variabilité des critères diagnostiques. Gastroenterol Clin Biol 2004;554-61.
15. Bommelaer G, Rouch M, Dapoigny M, Pais D, Loisy P, Gualino M, et al. Epidemiology of intestinal functional disorders in an apparently healthy population. Gastroenterol Clin Biol 1986; 10:7-12.
16. Bommelaer G, Dorval E, Denis P, Czernichow P, Frexinos J, Pelc A, et al. Prevalence of irritable bowel syndrome in the French population according to the Rome I criteria. Gastroenterol Clin Biol 2002;26:1118-23.
17. Bi-Zhen W, Qi-Ying P. Functional bowel disorders in apparently healthy chinese people. Chinese J Epid 1988;9:345-9.
18. Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992;304:87-90.
19. Saito YA, Talley NJ, Melton J, Fett S, Zinsmeister AR, Locke GR. The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates. Neurogastroenterol Motil 2003;15: 687-94.
20. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003;17:643-50.
21. Harvey RF, Mauad EC, Brown AM. Prognosis in the irritable bowel syndrome: a 5-year prospective study. Lancet 1987;1:963-5.
22. Svendsen JH, Munck LK, Andersen JR. Irritable bowel syndrome-prognosis and diagnostic safety. A 5-year follow-up study. Scand J Gastroenterol 1985;20:415-8.
23. Research diagnostic questions for functional gastrointestinal disorders. Rome II modular questionaire: Investigator and respondent forms. In: Drossman DA, Corraziari E, Talley NJ, Thompson WG, Whitehead WE, eds. The Functional Gastrointestinal Disorders. McLean VA: Degnon Ass, 2000:669-714.
24. Muller-Lissner SA, Bollani S, Brummer RJ, Coremans G, Dapoigny M, Marshall JK, et al. Epidemiological aspects of irritable bowel syndrome in Europe and North America. Digestion 2001;64:200-4.
25. Cain Jarrett ME, Heitkemper M. Irritable bowel syndrome subtypes of diarrhea-predominant, constipation-predominant and alternating as defined by patient self-classification and Rome II (abstract). Gastroenterology 2003;124:A390.
26. Kellow JE, Delvaux M, Azpiroz F, Camilleri M, Quigley EM, Thompson DG. Principles of applied neurogastroenterology: physiology/motility-sensation. Gut 1999;45(Suppl 2):1117-1124.
27. Mouzas IA, Fragkiadakis N, Moschandreas J, Karachristos A, Skordilis P, Kouroumalis E, et al. Validation and results of a questionnaire for functional bowel disease in out-patients. BMC Public Health 2002;2:8.
28. Vanner SJ, Depew WT, Paterson WG, DaCosta LR, Groll AG, Simon JB, et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastroenterol 1999;94:2912-7.
29. Whitehead WE, Palsson OS, Levy RL, Feld AD, Von Korff M, Drossman DA, et al. Agreement of Rome criteria with clinical diagnosis of irritable bowel syndrome (abstract). Gastroenterology 2003;124: A397.
30. Charapata CM, Mertz H. Who knows the Rome criteria? (abstract). Gastroenterology 2003;124:A394.
31. Longstreth GF. Clinical diagnosis of irritable bowel syndrome. In: Camilleri M, Spiller RC, eds. The Irritable Bowel Syndrome: Diagnostic and treatment. New York: Saunders WB, 2002:1-10.
32. Fass R, Longstreth GF, Pimentel M, Fullerton S, Russak SM, Chiou CF, et al. Evidence- and consensus-based practice guidelines for the diagnosis of irritable bowel syndrome. Arch Intern Med 2001;161: 2081-8.
33. Whitehead WE, Wald A, Diamant NE, Enck P, Pemberton JH, Rao SS. Functional disorders of the anus and rectum. Gut 1999;45(Suppl 2):1155-1159.
34. Drossman DA, Corraziari E, Talley NJ, Thompson WG, Whitehead WE. Rome II: Multinational consensus document on functional gastrointestinal disorders. Gut 1999;45(Suppl 2):111-81.
35. Talley NJ. Evaluation of drug treatment in irritable bowel syndrome. Br J Clin Pharmacol 2003;56:362-9.
36. Horton R. Lotronex and the FDA: a fatal erosion of integrity. Lancet 2001;357:1544-5.
37. Hammer J, Eslick GD, Howell SC, Altiparmak E, Talley NJ. Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut 2004;53:666-72.
38. Tolliver BA, Herrera JL, DiPalma JA. Evaluation of patients who meet clinical criteria for irritable bowel syndrome. Am J Gastroenterol 1994;89:176-8.